SCHEMBL16454812

SCHEMBL16454812

COc1ccccc1-c1nnc2c(C(=O)Nc3ccc(C)c(C)c3)cccn12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ RAB9A P51151 4/20 0.47
▸ NPC1 O15118 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ POLB P06746 3/20 0.47
▸ KCNK3 O14649 2/20 0.47
▸ KCNK9 Q9NPC2 2/20 0.47
▸ RXFP1 Q9HBX9 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ TP53 P04637 1/20 0.46
▸ SMO Q99835 1/20 0.45
▸ TOP1 P11387 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16454875 0.88 KCNK3 (0.53) MAPTALDH1A1HTTRAB9ANPC1
SCHEMBL16454853 0.88 ALDH1A1 (0.46) MAPTALDH1A1HTTCYP1A2POLB
SCHEMBL16454827 0.88 IDO1 (0.48) MAPTALDH1A1HTTRAB9ANPC1
SCHEMBL16454829 0.86 KCNK3 (0.49) MAPTALDH1A1HTTRAB9ANPC1
SCHEMBL16454858 0.86 IDO1 (0.52) MAPTALDH1A1HTTRAB9ANPC1
SCHEMBL16454784 0.85 TSHR (0.46) MAPTALDH1A1HTTRAB9ANPC1
SCHEMBL16454789 0.81 CHRNA7 (0.44) MAPTALDH1A1HTTRAB9ANPC1
SCHEMBL16454809 0.81 TSHR (0.53) MAPTALDH1A1HTTRAB9ANPC1
SCHEMBL16454874 0.81 ALDH1A1 (0.46) ALDH1A1HTTRAB9ANPC1KMT2A
SCHEMBL16454869 0.80 KMT2A (0.49) MAPTALDH1A1HTTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015020565-A1 SUBSTITUTED [1,2,4]TRIAZOLO[4,3-A]PYRIDINES EXHIBITING ANTAGONIST PROPERTIES TO ADENOSINE A2A RECEPTORS, AND USE THEREOF ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НЬЮВАК" (ООО "НЬЮВАК") (RU) 2015-02-12 — — WO disclosed
Send feedback